© Reuters. Merck&Co Earnings, Revenue Beat in Q3
Investing.com – Merck&Co reported on Thursday third quarter that beat analysts’ forecasts and revenue that topped expectations.
Merck&Co announced earnings per share of $1.85 on revenue of $15.00. Analysts polled by Investing.com anticipated EPS of $1.75 on revenue of $14.07B.
Merck&Co shares are down 4% from the beginning of the year, still down 0.71% from its 52 week high of $101.47 set on October 27.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment